Adam Ron
Stock Analyst at B of A Securities
(2.32)
# 2,661
Out of 4,970 analysts
15
Total ratings
54.55%
Success rate
10.04%
Average return
Main Sectors:
Stocks Rated by Adam Ron
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALHC Alignment Healthcare | Maintains: Buy | $16 → $19 | $16.32 | +13.39% | 1 | Mar 4, 2025 | |
| ASTH Astrana Health | Maintains: Buy | $55 → $49 | $30.70 | +59.61% | 1 | Mar 4, 2025 | |
| OSCR Oscar Health | Downgrades: Underperform | $21 → $14 | $17.68 | -23.64% | 11 | Nov 6, 2024 | |
| PRVA Privia Health Group | Downgrades: Neutral | $27 → $21 | $23.14 | -9.25% | 2 | Feb 22, 2024 |
Alignment Healthcare
Mar 4, 2025
Maintains: Buy
Price Target: $16 → $19
Current: $16.32
Upside: +13.39%
Astrana Health
Mar 4, 2025
Maintains: Buy
Price Target: $55 → $49
Current: $30.70
Upside: +59.61%
Oscar Health
Nov 6, 2024
Downgrades: Underperform
Price Target: $21 → $14
Current: $17.68
Upside: -23.64%
Privia Health Group
Feb 22, 2024
Downgrades: Neutral
Price Target: $27 → $21
Current: $23.14
Upside: -9.25%